AUG 31, 2022 8:29 AM PDT

Study Finds CBD is Effective for Young People with Drug Resistant Anxiety

WRITTEN BY: Kerry Charron

A pilot study conducted by Orygen (Australia’s Centre of Excellence in Youth Mental Health) and published in the Australian Journal of General Practice has indicated that cannabidiol significantly reduced symptoms of young people with extreme forms of anxiety that are unresponsive to other drug therapies. The Cannabidiol Youth Anxiety Pilot Study (CAPS) found that participants averaged a 42.6% reduction in anxiety symptoms following CBD treatment. Cannabidiol (CBD) is a non-intoxicating cannabis compound with a range of therapeutic uses, but it has gained recent research attention due to its anti-anxiolytic properties. 

The study included 30 participants (aged 12-25 years) with a diagnosed anxiety disorder. One specific criterion was that the participants had not experienced improvement after five cognitive behavioral therapy (CBT) sessions that calendar year. Participants took 200 mg of cannabidiol per day for one week, and then the dose was increased to 400 mg. Participants who did not show significant improvement had their dosage increased at 200mg increments up to 800mg per day. All participants were offered biweekly CBT for the duration of the study.

The findings are promising for emerging cannabinoid treatments. Current treatments such as CBT and selective serotonin reuptake inhibitor (SSRI) antidepressant drugs are only effective for 50% of patients with debilitating anxiety. Their symptoms and drug treatment plans are further complicated if patients with anxiety also suffer from depression and substance abuse disorders. Participants reported less tension, less panic attacks, and reduced use of illicit drugs to self-medicate. 

The researchers did not observe negative side effects such as suicidal thoughts, irritability or sleep problems that occasionally happen with SSRIs. The most common side effect was mild sedation or fatigue. Orygen Professor Dr. Paul Amminger explained the positive impact of CBD treatment on participants’ quality of life: “The young people had fewer panic attacks and could do things which they were previously unable to do like leave the house, go to school, participate in social situations, eat at restaurants, take public transport or attend appointments by themselves.” Current treatment for severe anxiety is limited, so these outcomes suggest CBD can help patients perform daily functions. 

Sources: Australian Journal of General Practice, Eureka News Alert

 

About the Author
BA and MA in English, MPS in Human Relations, and Ed.D. in Higher Education Administration
Kerry Charron writes about medical cannabis research. She has experience working in a Florida cultivation center and has participated in advocacy efforts for medical cannabis.
You May Also Like
NOV 18, 2022
Cell & Molecular Biology
Mitochondria Can Signal to the Immune & Nervous Systems
NOV 18, 2022
Mitochondria Can Signal to the Immune & Nervous Systems
Mitochondria are little organelles that have long been known as the powerhouses of the cell. But in recent years, scient ...
NOV 25, 2022
Immunology
Long-term Air Pollution Exposure Disrupts Immunity & Lymph Nodes
NOV 25, 2022
Long-term Air Pollution Exposure Disrupts Immunity & Lymph Nodes
As people age, their immune system does not function as well as it did when they were younger, probably due to natural a ...
DEC 05, 2022
Health & Medicine
Favorable and Unfavorable Prognostic Genes in Human Cancers
DEC 05, 2022
Favorable and Unfavorable Prognostic Genes in Human Cancers
Favorable and Unfavorable Prognostic Genes in Human Cancers Cancer is a leading cause of death worldwide, so there is an ...
NOV 30, 2022
Immunology
Rogue, Cancer-Linked Immune Cells Found to Drive Autoimmune Disorders
NOV 30, 2022
Rogue, Cancer-Linked Immune Cells Found to Drive Autoimmune Disorders
Leukemia patients are more likely to get autoimmune disorders like aplastic anemia or rheumatoid arthritis than unaffect ...
DEC 01, 2022
Drug Discovery & Development
The Impact of AI on Drug Discovery
DEC 01, 2022
The Impact of AI on Drug Discovery
Artificial Intelligence, also known as “AI”, has been the talk of the past year. AI performs and responds to ...
DEC 01, 2022
Neuroscience
Social Trauma Blocks Social Reward Neurons, Triggering Avoidance
DEC 01, 2022
Social Trauma Blocks Social Reward Neurons, Triggering Avoidance
Social trauma impairs social reward function in the brain, and thus triggers social avoidance in mice. The corresponding ...
Loading Comments...